← Leaderboards
Nathan N Alder
Texas A&M University Health Science Ctr
$4,561,620
Attributed
$4,948,799
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $935.5K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,948,799 · 4
By mechanism
R01$4,851,575 · 3
F32$97,224 · 1
Top collaborators
- Steven Michael Claypool2 shared
Most similar at Texas A&M University Health Science Ctr
Same institution · by research overlap
- Arthur D Laganowsky$6,242,643
- Dekai Zhang$1,029,462
- Ashley Nicole Kidwell$38,132
Others in their field
Top investigators on “Mitochondria”
- Bruce M Spiegelman · Dana-Farber Cancer Inst$30,163,696
- Shi Du Yan · Columbia University Health Sciences$29,685,201
- Peipei Ping · University Of California Los Angeles$27,344,561
- Mary McGrae McDermott · Northwestern University$25,752,019
- Vamsi Krishna Mootha · Massachusetts General Hospital$23,004,991
- Kenneth D. Tew · Fox Chase Cancer Center$22,000,362
Research focus
MitochondriaMembrane ModelMembraneOrganellesComplexResolutionSiteStructureThermodynamicsProteinsInsightLipidsYeastsCardiolipinsNanodiskMolecular DynamicsProtein TransportCrosslinkCoupledMolecularFluorescenceBindingMitochondrial MembraneAffect
Grant awards (15)
First-in-class peptide therapeutics for mitochondrial disorders: molecular mechanism of action and optimization of design$494,761
R01 · FY2024 · AG · contact PI
First-in-class peptide therapeutics for mitochondrial disorders: molecular mechanism of action and optimization of design$494,761
R01 · FY2023 · AG · contact PI
First-in-class peptide therapeutics for mitochondrial disorders: molecular mechanism of action and optimization of design$87,512
R01 · FY2023 · AG · contact PI
First-in-class peptide therapeutics for mitochondrial disorders: molecular mechanism of action and optimization of design$494,761
R01 · FY2022 · AG · contact PI
First-in-class peptide therapeutics for mitochondrial disorders: molecular mechanism of action and optimization of design$483,831
R01 · FY2021 · AG · contact PI
Mitochondrial membrane compartmentalization$372,533
R01 · FY2021 · GM
First-in-class peptide therapeutics for mitochondrial disorders: molecular mechanism of action and optimization of design$533,698
R01 · FY2020 · AG · contact PI
Mitochondrial membrane compartmentalization$401,826
R01 · FY2020 · GM
Investigation of the Subunit and Lipid Interactions of the Mitochondrial Protein Import Machinery$298,926
R01 · FY2019 · GM · contact PI
Investigation of the Subunit and Lipid Interactions of the Mitochondrial Protein Import Machinery$298,827
R01 · FY2018 · GM · contact PI
Investigation of the Subunit and Lipid Interactions of the Mitochondrial Protein Import Machinery$298,700
R01 · FY2017 · GM · contact PI
Investigation of the Subunit and Lipid Interactions of the Mitochondrial Protein Import Machinery$296,991
R01 · FY2016 · GM · contact PI
Investigation of the Subunit and Lipid Interactions of the Mitochondrial Protein Import Machinery$294,448
R01 · FY2015 · GM · contact PI
Analysis of Mitochondrial Protein Integration Mechanisms$49,928
F32 · FY2005 · GM
Analysis of Mitochondrial Protein Integration Mechanisms$47,296
F32 · FY2004 · GM